Neisseria meningitidis antigens and compositions

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S250100, C424S190100, C424S184100, C514S002600, C530S350000, C530S328000, C530S327000, C530S326000, C530S325000, C530S324000, C530S300000, C530S806000, C530S825000

Reexamination Certificate

active

07988979

ABSTRACT:
The invention provides proteins fromNeisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.

REFERENCES:
patent: 5514581 (1996-05-01), Ferrari et al.
patent: 5550213 (1996-08-01), Anderson et al.
patent: 5554372 (1996-09-01), Hunter
patent: 5668004 (1997-09-01), O'Donnell
patent: 6060065 (2000-05-01), Barney et al.
patent: 6355253 (2002-03-01), Zlotnick
patent: 7018636 (2006-03-01), Bhattacharjee et al.
patent: 2004/0033234 (2004-02-01), Berinstein et al.
patent: 2007/0026021 (2007-02-01), Fraser et al.
patent: 0818465 (1998-01-01), None
patent: 01144977 (1989-06-01), None
patent: WO-9213871 (1992-08-01), None
patent: WO-9408013 (1994-04-01), None
patent: WO-9601901 (1996-01-01), None
patent: WO-9629412 (1996-09-01), None
patent: WO-9633276 (1996-10-01), None
patent: WO-9713860 (1997-04-01), None
patent: WO-9737044 (1997-10-01), None
patent: WO 9957280 (1999-11-01), None
patent: WO-2006024954 (2006-03-01), None
Greenspan et al., Nature Biotechnology 17:936-937, 1999.
Cruse et al. Illustrated Dictionary of Immunology, 2nd Edn., CRC Press, pp. 46, 166 and 332, 2003.
Ala'Aldeen et al. Vaccine 12: 535-541, 1994, abstract.
Teerlink et al. J. Exp. Med. 166: 63-76, 1987.
Forest et al. Gene 192: 165-169, 1997.
Malorny et al. J. Bacteriol. 180: 1323-1330, 1998.
Gomez et al. Vaccine 14: 1340-1346, 1996.
Campbell, Am. (1984). “General Properties and Applications of Monoclonal Antibodies,” Chapter 1, inMonoclonal Antibody Technology, Elsevier Science Publishers:The Netherlands, pp. 1-32.
Sambrook, J. et al. (1989).Molecular Cloning, A Laboratory Manual. Second Edition, Cold Spring Harbor, pp. 17.1-17.44.
The printed output from the NCBI open reading frame finder. (12 pages).
Baeumler, A. J. et al. (1993). “Hypothetical 29.6 kD Protein in PCP 5' Region (ORF1),” Database Swissprot AC P31485.
Baumler, A. J. and K. Hantke (1992). “A Lipoprotein of Yersinia Enterocolitica Facilitates Ferrioxamine Uptake inEscherichia coli,” Journal of Bacteriology 174(3): 1029-1035.
Bernfield L. et al. (Sep. 2002). “Identification of a novel vaccine candidate for group BNeisseria meningitidis, ” Thirteenth International PathogenicNeisseriaConference, Norwegian Institute of Public Health, Oslo, Norway, p. 116.
Blake, M. S. and L. M. Wetzler. (1995). “Vaccines for Gonorrhoea: Where are We on the Curve?” Trends in Microbiology 3(12): 469-474.
Burland, V. et al. (1994). “Escherichia coliK-12 Chromosomal Region From 92.8 to 00.1 Minutes,” Database Empro1 AC U14003.
Conlin, C. A. et al. (1992). “Escherichia coliprIC Encodes an Endopeptidase and is Homologous to theSalmonella typhimuriumopdA Gene,” Journal of Bacteriology 174(18): 5881-5997.
Dempsey J.A. et al. (Nov. 1995). “The physical map of the chromosome of a serogroup A strain ofNeisseria meningitidisshows complex rearrangement relative to the chromosomes of the two mapped strains of the closely related speciesN. gonorrhoeae,” Journal of Bacteriology 177(22):6390-6400.
Dillard, J. P. et al. (1997) “A Peptidoglcan Hydrolase Similar to Bacteriophage Endolysins Acts as an Autolysin inNeisseria gonorrhoeae,” Molecular Microbiology 25(5): 893-907.
Farley J. et al. (Sep. 2002). “Characterization, cloning and expression of different subfamilies of the ORF 2086 gene fromNeisseria meningitidis,” Thirteenth International PathogenicNeisseriaConference, Norwegian Institute of Public Health, Oslo, Norway, p. 124.
Fletcher L.D. et al. (Apr. 2004). “Vaccine potential of theNeisseria meningitidis2086 lipoprotein,” Infection and Immunity 72(4):2088-2100.
Fleischmann, R. D. et al. (1995). “Hypothetical Protein HI0753,” Database Swissprot AC P44861.
Fleischmann, R. D. et al. (1995). “Oligopeptidase A (EC 3.4.24.70),” Database Swissprot AC P44573.
Hacker, J. et al. (1993). “Immunophilins: structure-function relationship and possible role in microbial pathogenicity,” Molecular Microbiology 10(3): 445-456.
Houghten et al. New Approaches to Immunization, Vaccines86, Cold Spring Harbor Laboratory, p. 21-25, 1986.
Huang, M. et al. (1995). “A Stomatin-Like Protein Necessary for Mechanosensation inC. elegans,” Nature 378(6554): 292-295.
Kaneko, T. (1996). “Membrane-Bound Lytic Transglycosylase A MItASynechocystissp. Strain PCC 6803,” Database TrEMBL AC Q55666.
Kohara Y. (Aug. 12, 1994). “Caenorhabditis eleganscDNA clone yk26f2: 5' end, single read,” Database accession No. D35881. Database EMBL [Online] EBI.
Lommatzsch, J. et al. (1997). “Outer Membrane Localization of Murein Hydrolases: MItA, A Third Lipoprotein Lytic Transglycosynlase inEscherichia coli,” Journal of Bacteriology 179(17): 5465-5470.
Masignani V. (Mar. 17, 2003). “Vaccination againstNeisseria meningitidisusing three variants of the lipoprotein GNA1870,” J. Exp. Med. 197(6):789-799.
McAllister, C. F. and D. S. Stephens. (1993). “Analysis inNeisseria meningitidisand otherNeisseriaspecies of genes homologous to the FKBP immunophilin family,” Molecular Microbiology 10(1): 13-23.
McAllister, C. F. et al. (1993). “Neisseria elongateNRL FKBP Immunophilin Homolog Gene,” Database Empro2 AC U001198.
McGuinness et al. (Feb 1993). “Class 1 outer membrane protein ofNeisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology,” Mol. Microbiol. 7:505-514.
McGuiness et al. (Mar. 1991). “Point mutation in meningococcal porA gene associated with increased endemic disease,” Lancet 337:514-517.
Poolman, J. T. (1995). “Development of a Meningococcal Vaccine,” Infectious Agents and Disease 4(1): 13-28.
Quentin-Millet, M. J. et al. (1998). “N. MeningitidisHTR Tbp2 (de13777-385, de1407-465, de 1488-508),” Database GCG—GenesEQ AC W14640.
Richard, M.E. (Oct. 25, 1997). “Applications of molecular microbiology to vaccinology,” Lancet (North American Edition) 350(9086): 1240-1244.
Rokbi et al. (1998). “Transferrin Binding Protein B, TbpB,Neisseria Meningitidis,” Database TrEMBL AC 069750.
Rokbi, B. et al. (1997). “Evaluation of Recombinant Transferrin-Binding Protein B Variants fromNeisseria meningitidisfor their Ability to Induce Cross-Reactive and Bactericidal Antibodies Against a Genetically Diverse Collection of Serogroup B Strains,” Infection and Immunity 65(1): 55-63.
Rokbi, B. et al. (1997). “Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup BNeisseria meningitidisstrains of the ET-5 complex,” Clinical and Diagnostic Laboratory Immunology 4(5): 522-529.
Rudinger et al. (Jun. 1976).Peptide Hormones. (Ed) JA Parsons, University Park Press.
Sampson, B. and E. C. Gotschlich. (1992). “Neisseria meningitidisencodes an FK506-inhibitable rotamase,” Proc. Natl. Acad. Sci. USA 89(4): 1164-1168.
Smith C.J. et al. (1995). “Nucleotide sequence determination and genetic analysis of the Bacteroides plasmid, pBI143,” Plasmid 34(3):211-222.
Tettelin H et al. (Mar. 10, 2000). “Complete genome sequence ofNeisseria meningitidisserogroup B strain MC58,” Science 287(5459):789-799.
Wong, C. Y. et al. (1997). “Cloning and characterization of two immunophilin-like genes, ilpA and fkpA, on a single 3.9-kilobase fragment of Aeromonas hydrophila genomic DNA,” Journal of Bacteriology 179(11): 3397-3403.
You, Z. et al. (1997). “Rhizobium Etli Stomatin like Protein (slp) gene, complete cds.,” Database Empro1 AC AF034831.
You, Z. et al. (1998). “A Stomatin-Like Protein Encoded by the slp Gene of Rhizobium Etli is Required for Nodulation Competitiveness on the Common Bean,” Microbiology 144(9): 2619-2627.
International Search Report mailed on Jun.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Neisseria meningitidis antigens and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neisseria meningitidis antigens and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neisseria meningitidis antigens and compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2743781

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.